| Literature DB >> 32578671 |
José Luiz Fontoura-Andrade1, Leonardo Mendes Pinto2, Fabiana Pirani Carneiro3, João Batista de Sousa4.
Abstract
PURPOSE: To investigate the effect of hyperbaric oxygen therapy on colonic anastomosis healing with and without ischemia in rats.Entities:
Mesh:
Year: 2020 PMID: 32578671 PMCID: PMC7310584 DOI: 10.1590/s0102-865020200050000003
Source DB: PubMed Journal: Acta Cir Bras ISSN: 0102-8650 Impact factor: 1.388
Statistical results of breaking strength (in Newtons).
| Statistical results | Experimental Group | |||
|---|---|---|---|---|
|
| ||||
| Control | Ischemia | Ischemia/HBOT | HBOT | |
| p (Shapiro-Wilk) | 0.118 | 0.010 | 0.107 | 0.000 |
| Median | 0.03 | 0.03 | 0.13 | 0.02 |
| Interquartile range | 0.00-0.06 | 0.01-0.15 | 0.07-0.27 | 0.01-0.023 |
| Mean | 0.04 | 0.09 | 0.17 | 0.24 |
| Standard deviation | 0.04 | 0.11 | 0.14 | 0.54 |
| Standard error | 0.01 | 0.04 | 0.05 | 0.17 |
| 95% confidence interval | ||||
| Lower limit | 0.01 | 0.01 | 0.05 | -0.14 |
| Upper limit | 0.07 | 0.17 | 0.28 | 0.62 |
| 5% trimmed mean | 0.04 | 0.08 | 0.16 | 0.17 |
| Variance | 0.00 | 0.01 | 0.02 | 0.29 |
| Minimum | 0.00 | 0.00 | 0.03 | 0.00 |
| Maximum | 0.13 | 0.35 | 0.43 | 1.72 |
| Range | 0.13 | 0.35 | 0.40 | 1.72 |
HBOT = Hyperbaric Oxygen Therapy
Relative frequency of histopathology findings stratified by group. Frequencies that were zero in all groups were not listed in the table.
| Experimental Group | ||||
|---|---|---|---|---|
|
| ||||
| Control | Ischemia | Ischemia/HBOT | HBOT | |
| Collagen | ||||
| Absent | 11.11% | 14.29% | 37.50% | 0.00% |
| Mild | 77.78% | 85.71% | 62.50% | 88.89% |
| Moderate | 11.11% | 0.00% | 0.00% | 11.11% |
| Fibroblast | ||||
| Absent | 11.11% | 0.00% | 12.50% | 0.00% |
| Mild | 11.11% | 14.29% | 25.00% | 0.00% |
| Moderate | 77.78% | 85.71% | 62.50% | 100.00% |
| Mononuclear leukocyte infiltrate | ||||
| Mild | 22.22% | 28.57% | 12.50% | 22.22% |
| Moderate | 77.78% | 71.43% | 87.50% | 77.78% |
| Polynuclear leukocyte infiltrate | ||||
| Absent | 11.11% | 0.00% | 0.00% | 0.00% |
| Mild | 11.11% | 14.29% | 0.00% | 11.11% |
| Moderate | 33.33% | 14.29% | 37.50% | 11.11% |
| Intense | 44.44% | 71.43% | 62.50% | 77.78% |
| Hemorrhage and congestion | ||||
| Absent | 44.44% | 28.57% | 50.00% | 44.44% |
| Mild | 33.33% | 71.43% | 50.00% | 55.56% |
| Moderate | 22.22% | 0.00% | 0.00% | 0.00% |
| Neovascularization | ||||
| Mild | 0.00% | 0.00% | 37.50% | 11.11% |
| Moderate | 100.00% | 100.00% | 62.50% | 88.89% |
| Edema | ||||
| Mild | 66.67% | 85.71% | 75.00% | 88.89% |
| Moderate | 33.33% | 14.29% | 12.50% | 11.11% |
| Intense | 0.00% | 0.00% | 12.50% | 0.00% |
HBOT = Hyperbaric Oxygen Therapy
Relative histopathology findings listed by experimental group.
| Groups | Control | Ischemia | Ischemia/HBOT | HBOT |
|---|---|---|---|---|
| Ulceration | ||||
| Absent | 22% | 0% | 0% | 11% |
| Present | 78% | 100% | 100% | 89% |
| Fibrin-leukocyte crust | ||||
| Absent | 33% | 0% | 11% | |
| Present | 67% | 100% | 100% | 89% |
| Ischemic necrosis | ||||
| Absent | 89% | 100% | 75% | 78% |
| Present | 11% | 0% | 25% | 22% |
| Microabscess | ||||
| Absent | 33% | 29% | 12% | 11% |
| Present | 67% | 71% | 88% | 89% |
| Bacterial colonies | ||||
| Absent | 44% | 71% | 38% | 56% |
| Present | 56% | 29% | 62% | 44% |
| Foreign body | ||||
| Absent | 89% | 100% | 75% | 100% |
| Present | 11% | 0% | 25% | 0% |
| Separation of wound edges | ||||
| Absent | 56% | 43% | 38% | 56% |
| Present | 44% | 57% | 62% | 44% |
| Reepithelialization | ||||
| Absent | 44% | 43% | 75% | 33% |
| Partial | 34% | 57% | 25% | 67% |
| Overall | 22% | 0% | 0% | 0% |
HBOT = Hyperbaric Oxygen Therapy
Statistical results of body mass on the first and seventh day of experiment.
| 1st of experiment | 7th day of experiment | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Control | Ischemia | Ischemia/HBOT | HBOT | Control | Ischemia | Ischemia/HBOT | HBOT | |
| p (Saphiro wilk) | 0.507 | 0.173 | 0.046 | 0.116 | 0.424 | 0.148 | 0.035 | 0.340 |
| Median | 219 | 218.5 | 220 | 222 | 206 | 198.5 | 202 | 208 |
| First quartile | 209 | 212.50 | 215.75 | 218.50 | 193.25 | 193.50 | 196.50 | 193.25 |
| Third Quartile | 237.25 | 243.75 | 226.25 | 230 | 216 | 222 | 214 | 213 |
Statistical results of clinical parameters on days 4th, 5th and 6th.
| Clinical parameter | Experimental Group | 4th day | 5th day | 6th day | |||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Mean | Standard deviation | Mean | Standard deviation | Mean | Standard deviation | ||
| Chromodacryorrhea | Control | 0.78 | 0.44 | 0.67 | 0.50 | 0.50 | 0.54 |
| Ischemia | 0.88 | 0.35 | 0.88 | 0.35 | 0.38 | 0.52 | |
| Ischemia/HBOT | 1.10 | 0.32 | 0.70 | 0.48 | 0.50 | 0.53 | |
| HBOT | 1.00 | 0.00 | 0.70 | 0.48 | 0.40 | 0.52 | |
| changes in ear and whisker position | Control | 0.00 | 0.00 | ||||
| Ischemia | 0.00 | 0.00 | |||||
| Ischemia/HBOT | 0.20 | 0.42 | |||||
| HBOT | 0.00 | 0.00 | |||||
| Reduced activity | Control | 0.33 | 0.50 | 0.11 | 0.33 | ||
| Ischemia | 0.38 | 0.52 | 0.13 | 0.35 | |||
| Ischemia/OT | 0.50 | 0.53 | 0.20 | 0.42 | |||
| HBOT | 0.60 | 0.52 | 0.20 | 0.42 | |||
| sucked-in flanks | Control | 0.22 | 0.44 | 0.00 | 0.00 | ||
| Ischemia | 0.13 | 0.35 | 0.00 | 0.00 | |||
| Ischemia/HBOT | 0.20 | 0.42 | 0.20 | 0.42 | |||
| HBOT | 0.30 | 0.48 | 0.10 | 0.32 | |||
| Piloerection | Control | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Ischemia | 0.13 | 0.35 | 0.00 | 0.00 | |||
| Ischemia/HBOT | 0.10 | 0.32 | 0.20 | 0.42 | |||
| HBOT | 0.10 | 0.32 | 0.00 | 0.00 | |||
Relative and absolute frequency of animals listed by experimental group, Nair score, and anastomotic leak.
| Nair Score | 0 | 1 | 2 | 3 | 4 | - | Not evaluated |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Absent | One band | Two bands | Three or more bands | Adhesions to abdominal wall | Anastomotic leak | ||
| Experimental Group | |||||||
| Ischemia/HBOT | 0 | 0 | 7 (70%) | 3 (30%) | 0 | 0 | 0 |
| HBOT | 0 | 0 | 5 (50%) | 5 (50%) | 0 | 0 | 0 |
| Ischemia | 0 | 0 | 2 (25%) | 6 (75%) | 0 | 2 | 2 |
| Control | 0 | 1 (11.11%) | 1 (11.11%) | 7 (77.77%) | 0 | 0 | 1 |
HBOT = Hyperbaric Oxygen Therapy